Association of Statins and 28-Day Mortality in Patients Hospitalized with SARS CoV-2 Infection.
Zoe N MemelJenny J LeeAndrea S FoulkesRaymond T ChungTanayott ThaweethaiPatricia P BloomPublished in: The Journal of infectious diseases (2021)
Statin use during hospitalization for SARS-CoV-2 infection was associated with reduced 28-day mortality. Well-designed randomized control trials are needed to better define this relationship.
Keyphrases
- end stage renal disease
- cardiovascular disease
- cardiovascular events
- chronic kidney disease
- respiratory syndrome coronavirus
- coronary artery disease
- prognostic factors
- peritoneal dialysis
- double blind
- randomized controlled trial
- type diabetes
- placebo controlled
- patient reported outcomes
- patient reported
- phase ii
- sars cov
- phase iii